Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma

Ward, C.; Pais, M.; Bish, R.; Reid, D.; Feltis, B.; Johns, D.; Walters, E. H.
April 2002
Thorax;Apr2002, Vol. 57 Issue 4, p309
Academic Journal
Background: There are few data in asthma relating airway physiology, inflammation and remodelling and the relative effects of inhaled corticosteroid (ICS) treatment on these parameters. A study of the relationships between spirometric indices, airway inflammation, airway remodelling, and bronchial hyperreactivity (BHR] before and after treatment with high dose inhaled fluticasone propionate (FP 750 μg bd) was performed in a group of patients with relatively mild but symptomatic asthma. Methods: A double blind, randomised, placebo controlled, parallel group study of inhaled FP was performed in 35 asthmatic patients. Bronchoalveolar lavage (BAL) and airway biopsy studies were carried out at baseline and after 3 and 1 2 months of treatment. Twenty two normal healthy non-asthmatic subjects acted as controls. Results: BAL fluid eosinophils, mast cells, and epithelial cells were significantly higher in asthmatic patients than in controls at baseline (p<0.01). Subepithelial reticular basement membrane (rbm) thickness was variable, but overall was increased in asthmatic patients compared with controls (p<0.01). Multiple regression analysis explained 40% of the variability in BHR, 21% related to rbm thickness, 11% to BAL epithelial cells, and 8% to BAL eosinophils. The longitudinal data corroborated the cross sectional model. Forced expiratory volume in 1 second improved after 3 months of treatment with FP with no further improvement at 12 months. PD20 improved throughout the study. BAL inflammatory cells decreased following 3 months of treatment with no further improvement at 12 months (p 0.05 v placebo). Rbm thickness decreased in the FP group, but only after 12 months of treatment (mean change -1.9, 95% Cl -3 to -0.7 μm; p<0.01 v baseline, p<0.05 v placebo). A third of the improvement in BHR with FP was associated with early changes in inflammation, but the more progressive and larger improvement was associated with the later improvement in airway remodelling. Conclusion: Physiology, airway inflammation and remodelling in asthma are interrelated and improve with ICS. Changes are not temporally concordant, with prolonged treatment necessary for maximal benefit in remodelling and PD20. Determining the appropriate dose of inhaled steroids only by reference to symptoms and lung function, as specified in current international guidelines, and even against indices of inflammation may be over simplistic. The results of this study support the need for early and long term intervention with ICS, even in patients with relatively mild asthma.


Related Articles

  • MicroRNA Expression Profiling in Mild Asthmatic Human Airways and Effect of Corticosteroid Therapy. Williams, Andrew E.; Larner-Svensson, Hanna; Perry, Mark M.; Campbell, Gaynor A.; Herrick, Sarah E.; Adcock, Ian M.; Erjefalt, Jonas S.; Kian Fan Chung; Lindsay, Mark A. // PLoS ONE;2009, Vol. 4 Issue 6, p1 

    Background: Asthma is a common disease characterised by reversible airflow obstruction, bronchial hyperresponsiveness and chronic inflammation, which is commonly treated using corticosteroids such as budesonide. MicroRNAs (miRNAs) are a recently identified family of non-protein encoding genes...

  • Glutathione in induced sputum of healthy individuals and patients with asthma. Dauletbaev, N.; Rickmann, J.; Viel, K.; Buhl, R.; Wagner, T-O-F.; Bargon, J. // Thorax;Jan2001, Vol. 56 Issue 1, p13 

    Background-Glutathione is central to the antioxidant defenses of the lung. The aim of this study was to determine whether sputum induction can be used for the measurement of glutathione in the respiratory tract. Methods-Saliva and induced sputum (3% NaCl, 20 minutes) samples were collected from...

  • Vitex rotundifolia L. prevented airway eosinophilic inflammation and airway remodeling in an ovalbumin-induced asthma mouse model. Bae, Hyunsu; Kim, Youngeun; Lee, Euijeong; Park, Soojin; Jung, Kyung-Hwa; Gu, Min-Jung; Hong, Seon-Pyo; Kim, Jinju // International Immunology;Mar2013, Vol. 25 Issue 3, p197 

    A traditional medicine from Vitex rotundifolia ameliorates asthma symptoms.Vitex rotundifolia L. (VR) as long been used in China and Korea in traditional medicine. This study was conducted to evaluate the ability of Vitex rotundifolia L. to prevent airway inflammation and remodeling in an...

  • Ultrastructural examination of bronchial biopsy specimens from children with moderate asthma. Çoku&gcaron;raş, H; Akçakaya, N.; Seçkin, İ.; Camcio&gcaron;lu, Y.; Sarimurat, N.; Aksoy, F. // Thorax;Jan2001, Vol. 56 Issue 1, p25 

    Background-Few studies have evaluated the asthmatic airway in childhood. The aim of this study was to assess the histopathological changes occurring in the bronchi of children with moderate asthma using light and electron microscopy. Methods-Bronchial biopsy specimens from 10 children with...

  • Diagnosis and treatment of refractory asthma. URSO, D. L.; VINCENZO, D.; PIGNATARO, F.; ACRI, P.; CUCINOTTA, G. // European Review for Medical & Pharmacological Sciences;Sep/Oct2008, Vol. 12 Issue 5, p315 

    Asthma is an inflammatory disorder of the airway associated with airflow obstruction and bronchial hyperresponsiveness that varies in severity across the spectrum of the disease. Asthma affects 5-7% of the population of North America and Europe, and the prevalence is increasing. Most patients...

  • Feasibility and acceptability of using bronchial hyperresponsiveness to manage asthma in primary care: a pilot study. Turton, James A.; Glasgow, Nicholas J.; Brannan, John D. // Primary Care Respiratory Journal;Mar2012, Vol. 21 Issue 1, p28 

    Aims: To determine if indirect testing for bronchial hyperresponsiveness (BHR) to monitor inhaled corticosteroid (ICS) treatment in asthma is feasible and acceptable in primary care. Methods: Fourteen adult patients with asthma aged 22-70 years (4M:10F, forced expiratory volume in 1 s >70%...

  • Cell specific markers for eosinophils and neutrophils in sputum and bronchoalveolar lavage fluid of patients with respiratory conditions and healthy subjects. Metso, T.; Venge, P.; Haahtela, T.; Peterson, C. G. B.; Sevéus2, L.; Metso, Tuula; Sevéus, L // Thorax;May2002, Vol. 57 Issue 5, p449 

    Background: Highly specific protein markers for eosinophils and neutrophils could be a valuable diagnostic aid in various respiratory disorders. The cell specificity of monoclonal antibodies against eosinophil peroxidase (EPO), eosinophil cationic protein (ECP), human neutrophil...

  • Acetamide-45 inhibited hyperresponsiveness and airway inflammation in mice partly depending on phosphodiesterase activity suppression. Kai WANG; Hua-hao SHEN; Hua-qiong HUANG; Jun-chun CHEN; Zhong CHEN // Acta Pharmacologica Sinica;Oct2008, Vol. 29 Issue 10, p1195 

    Aim: Asthma is characterized as a chronic inflammatory disorder of the airways. Phosphodiesterases (PDE), which hydrolyze cAMP, are considered to play important roles in asthma. We previously reported that acetamide-45 could inhibit cAMP-PDE activity, and histamine- and methacholine-induced...

  • Associations of airway inflammation and responsiveness markers in non asthmatic subjects at start of apprenticeship. Demange, Valérie; Wild, Pascal; Zmirou-Navier, Denis; Tossa, Paul; Bohadana, Abraham; Barbaud, Annick; Paris, Christophe // BMC Pulmonary Medicine;2010, Vol. 10, p37 

    Background: Bronchial Hyperresponsiveness (BHR) is considered a hallmark of asthma. Other methods are helpful in epidemiological respiratory health studies including Fractional Exhaled Nitric Oxide (FENO) and Eosinophils Percentage (EP) in nasal lavage fluid measuring markers for airway...


Read the Article


Sign out of this library

Other Topics